Lexeo Therapeutics
LXEO
LXEO
109 hedge funds and large institutions have $328M invested in Lexeo Therapeutics in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
35.94% less ownership
Funds ownership: 127.34% → 91.4% (-36%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
76% less call options, than puts
Call options by funds: $27K | Put options by funds: $111K
Holders
109
Holding in Top 10
1
Calls
$27K
Puts
$111K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$9.21M | |
| 3 | +$8.59M | |
| 4 |
6CM
683 Capital Management
New York
|
+$6.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.75M |
Top Sellers
| 1 | -$4.76M | |
| 2 | -$3.49M | |
| 3 | -$3.47M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$633K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$146K |
